Current Understanding of Clinical Manifestations of COVID-19 in Glomerular Disease.

ABSTRACT:

Background

The novel coronavirus disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an evolving pandemic with significant mortality. Information about the impact of infection on glomerular disease patients in particular has been lacking. Understanding the virus's effect in glomerular disease is constantly changing. This review article summarizes the data published thus far on COVID-19 and its manifestations in pre-existing and de novo glomerular disease.

Summary

While patients with glomerular disease may be at higher risk of severe COVID-19 due to their immunosuppressed status, some data suggest that a low amount of immunosuppression may be helpful in mitigating the systemic inflammatory response which is associated with high m

SUBMITTER: Shimmel A 

PROVIDER: S-EPMC8450860 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature